Sam Hulsey is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Mr. Hulsey participates in the representation of public and private companies in mergers, acquisitions and divestitures.
Mr. Hulsey has participated in advising:
- athenahealth, Inc. in its $5.7 billion sale to Veritas Capital and Evergreen Coast Capital (an affiliate of Elliott Management Corporation) and planned combination with Virence Health
- Carlin America, Inc. in its $245 million sale to Round Hill Music, LLC
- Dow Inc. in its approximately $40 billion spin-off from DowDuPont Inc. as part of DowDuPont's separation into three independent, publicly traded companies
- Eli Lilly and Company in its $1.1 billion acquisition of Dermira, Inc.
- Special Committee of Fidelity National Financial, Inc. (FNF) in FNF's $2.7 billion acquisition of FGL Holdings
- Fogo de Chão Churrascaria (Holdings), LLC (a publicly traded company backed by Thomas H. Lee Partners) in its $560 million take-private sale to Rhône Capital
- General Electric Company in its $2.6 billion sale of GE Industrial Solutions
- The Kroger Company in the $2.15 billion sale of its convenience store business unit to EG Group
- Magellan Health, Inc. in its $850 million sale of Magellan Complete Care to Molina Healthcare, Inc.
- Ontario Teachers' Pension Plan in the sale of its stake in Cole-Parmer Instrument Company (C-P) to GTCR in connection with a $2.1 billion recapitalization of C-P led by GTCR in which Golden Gate Capital and C-P management retained minority stakes
- Quest Diagnostics Inc. in its acquisition of the U.S. laboratory services business of Oxford Immunotec Global PLC
- Sanofi in its $11.6 billion acquisition of Bioverativ Inc. and in its $350 million sale of its Seprafilm Adhesion Barrier and related assets to Baxter International Inc.
- Willis Towers Watson PLC in its pending $80 billion combination with Aon PLC
Mr. Hulsey received his J.D. from New York University School of Law and his B.A. from USC (Southern California).